Bandar Alqarni/X
Sep 29, 2025, 11:36
Bandar Alqarni: Smoflipid 20% Use in IVF Protocols
Bandar Alqarni, Pharmacist in Riyadh, shared a post on X:
“Smoflipid 20% is gaining attention for its off-label use in IVF protocols, especially in cases of Recurrent Implantation Failure (RIF) or Recurrent Pregnancy Loss (RPL).
It may help by:
- Reducing NK cell activity
- Enhancing immune tolerance
- Supporting embryo implantation
While not considered a formal treatment, it is an option in select cases after ruling out organic and chromosomal causes. Its use is under strict medical supervision, often as part of an integrated immunotherapy plan.
Always consult your fertility specialist.”
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 16, 2025, 15:03Always a Great Pleasure Returning to St. Jude Children’s Research Hospital – Gevorg Tamamyan
-
Dec 16, 2025, 14:45Chemical Pollution’s Impact on Male Reproductive Health – Cesar Fertility
-
Dec 16, 2025, 14:27Discover This Month’s Must-Read Articles – Fertility and Sterility
-
Dec 16, 2025, 13:20New Diagnostic Tools for Infertility Explored in Latest Review – Reproductive BioMedicine Online
-
Dec 15, 2025, 15:33Severe Postpartum Hemorrhage: Advances in Care Techniques – AGOF Asso Gynéco Obs en Formation
-
Dec 15, 2025, 15:27Silvia Alvarez: Key Findings on Egg Freezing Impact
-
Dec 14, 2025, 16:45Navigating Women’s Health Across Life Stages at SIGO – AOGOI
-
Dec 14, 2025, 16:38Steven Palter: The Role of Nutrition in Managing Infertility Explored
-
Dec 14, 2025, 16:19Impact of Preconception Metabolic Health on Fertility – Carrot